Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit

• Main Authors: Rotolo, S.M (Author), Warda, N. (Author)
• Format: Article
• Language: English
• Published: Elsevier B.V. 2021
• Subjects: adult; adverse event; Article; child; Child; clinical article; controlled study; coronavirus disease 2019; COVID-19; cystic fibrosis; Cystic Fibrosis; drug storage; female; health care planning; human; Humans; humidity; light exposure; lung fibrosis; male; medical history; medication therapy management; multidisciplinary team; non prescription drug; nutrition supplement; pandemic; Pandemics; patient compliance; pharmacist; Pharmacists; prescription drug; prospective study; responsibility; SARS-CoV-2; telehealth; telemedicine; Telemedicine; temperature; virtual reality; vitamin
• Online Access: View Fulltext in Publisher

 Background: As a result of the coronavirus disease 2019 (COVID-19) pandemic, institutions needed innovative solutions to provide care. With implementation of telehealth, a cystic fibrosis (CF) pharmacist was able to incorporate a virtual medication tour during appointments. Objective: The purpose of our study was to describe the uptake and impact of pharmacist-led virtual medication tours during telehealth visits in the CF clinic setting. Practice description: Before the COVID-19 pandemic, a CF pharmacist participated in in-person multidisciplinary team visits to complete medication history reconciliation, assess adherence, assess efficacy and address possible adverse effects of medications, and work collaboratively with the CF care team and patient to create therapeutic plans. The virtual medication tour described in this study was completed in addition or as a complement to these pre-existing pharmacist roles and responsibilities. Practice innovation: Patients seen via telehealth visit were asked to provide a virtual tour of their medications. A pharmacist completed medication history and evaluated whether storage conditions were appropriate in regard to temperature, humidity, light exposure, and accessibility to children. Evaluation methods: A pharmacist recorded findings from the virtual medication tours and made interventions when appropriate. Descriptive statistics were used for analysis. Results: Of 20 patients seen via telehealth for a quarterly visit during the first 3 months after implementation, 13 were willing to participate in a virtual medication tour. Before the visit, 25% had information missing from their medication list. Virtual medication tour allowed for resolution of this information 80% of the time. Three of the 4 participating patients with a child under 12 years old had medications stored in a location accessible to children. Conclusion: A virtual medication tour led by a pharmacist can be successfully incorporated into telehealth visits and was accepted by a majority of patients. Most patients stored medications appropriately but might benefit from education on poison prevention practices. © 2021 American Pharmacists Association®